Biogen and Apple Collaborate to Launch Virtual Study on Cognitive Decline


  • Biogen and Apple collaborated to evaluate the role of Apple Watch and iPhone in monitoring cognitive performance and screening for the decline in cognitive health including mild cognitive impairment (MCI)
  • The study will initiate in late 2021 and will enroll participants including young and aging adults with a range of cognitive performance
  • The study focuses to identify digital biomarkers to aid monitor cognitive performance and health including potentially detecting mild cognitive impairment, an early indicator of certain forms of dementia such as AD

Click here ­to­ read full press release/ article | Ref: Biogen | Image: MyHealthyApp

The post Biogen and Apple Collaborate to Launch Virtual Study on Cognitive Decline first appeared on PharmaShots.

#Healthin2Point00, Episode 166 | $100 million, scandal, & more

Today on Health in 2 Point 00, we have scandal, drama, intrigue, $100 million and murder! Wait, no; not murder. On Episode 166, we catch up on more deals before Jess gets carried away again. The $100 million goes to Carbon Health in a Series C, which is another Bay Area-based primary care startup; they’re doing a lot of work in COVID testing and growing fast. Next we have many health plans uniting with Cigna Ventures, Humana, and Anthem all investing in Buoy Health which just raised $37.5 million in a Series C. That leads us to a scandal with the former CEO of Navigating Cancer suing Merck’s Global Health Innovation Fund. Finally, in the world of DTx, NightWare has received FDA clearance for its Apple Watch app designed to wake people with PTSD up from nightmares. —Matthew Holt